We are live on ! Find out more
BFA

BlackRock Fund Advisors Portfolio holdings

AUM $542B
1-Year Est. Return 18.13%
This Fund
S&P 500
This Quarter Est. Return
+3.01%
1 Year Est. Return
+18.13%
3 Year Est. Return
+41.39%
5 Year Est. Return
10 Year Est. Return
AUM
$337B
AUM Growth
+$8.63B
Cap. Flow
+$2.7B
Cap. Flow %
0.8%
Top 10 Hldgs %
9.68%
Holding
3,915
New
60
Increased
2,592
Reduced
1,000
Closed
56

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$563M
2
PRGO icon
Perrigo
PRGO
+$313M
3
PFE icon
Pfizer
PFE
+$301M
4
VER
VEREIT, Inc.
VER
+$168M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$156M

Sector Composition

Rank Sector Weight
1 Financials 12.86%
2 Healthcare 12.68%
3 Technology 12.62%
4 Industrials 11.62%
5 Consumer Discretionary 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCM icon
2826
Stellus Capital Investment Corp
SCM
$217M
$4.92M ﹤0.01%
342,051
+4,198
+1% +$61.5K
RC
2827
Ready Capital
RC
$258M
$4.91M ﹤0.01%
294,921
+23,389
+9% +$397K
PLPC icon
2828
Preformed Line Products
PLPC
$1.74B
$4.91M ﹤0.01%
71,647
+1,052
+1% +$69.9K
ENVE
2829
DELISTED
ENVENTIS CORP COM STK
ENVE
$4.9M ﹤0.01%
382,817
+8,399
+2% +$114K
TEVA icon
2830
Teva Pharmaceuticals
TEVA
$40.8B
$4.89M ﹤0.01%
92,598
+34,400
+59% +$1.59M
ARTNA icon
2831
Artesian Resources
ARTNA
$355M
$4.89M ﹤0.01%
217,756
+1,221
+0.6% +$27.2K
SVA
2832
DELISTED
Sinovac Biotech, Ltd
SVA
$4.88M ﹤0.01%
677,179
+43,815
+7% +$290K
ESPR
2833
DELISTED
Esperion Therapeutics
ESPR
$4.87M ﹤0.01%
322,343
+23,506
+8% +$365K
MGNX icon
2834
MacroGenics
MGNX
$235M
$4.86M ﹤0.01%
174,758
+17,330
+11% +$612K
ACHV icon
2835
Achieve Life Sciences
ACHV
$659M
$4.85M ﹤0.01%
188
+6
+3% +$147K
UMH
2836
UMH Properties
UMH
$1.29B
$4.85M ﹤0.01%
495,654
+6,724
+1% +$63.5K
AVHI
2837
DELISTED
A V Homes, Inc.
AVHI
$4.85M ﹤0.01%
267,947
+7,396
+3% +$139K
NRIM icon
2838
Northrim BanCorp
NRIM
$590M
$4.85M ﹤0.01%
754,552
+9,264
+1% +$58.1K
HDNG
2839
DELISTED
Hardinge Inc
HDNG
$4.84M ﹤0.01%
336,318
+8,730
+3% +$124K
PSTV icon
2840
Plus Therapeutics
PSTV
$26.6M
$4.83M ﹤0.01%
1
BMA icon
2841
Banco Macro
BMA
$5.88B
$4.82M ﹤0.01%
171,300
+38,845
+29% +$870K
BOLT
2842
DELISTED
BOLT TECHNOLOGY CORPORATION
BOLT
$4.82M ﹤0.01%
243,628
+2,422
+1% +$49.7K
PZG icon
2843
Paramount Gold Nevada
PZG
$96.1M
$4.81M ﹤0.01%
3,912,318
+114,964
+3% +$141K
WIX icon
2844
WIX.com
WIX
$2.3B
$4.8M ﹤0.01%
209,028
+2,458
+1% +$67K
HURC icon
2845
Hurco Companies Inc
HURC
$135M
$4.79M ﹤0.01%
179,672
+1,940
+1% +$49.3K
VERU icon
2846
Veru
VERU
$36M
$4.79M ﹤0.01%
61,765
+3,100
+5% +$228K
GGAL icon
2847
Galicia Financial Group
GGAL
$7.99B
$4.79M ﹤0.01%
388,935
+88,895
+30% +$855K
MRLN
2848
DELISTED
Marlin Business Services Corp
MRLN
$4.78M ﹤0.01%
229,840
+1,504
+0.7% +$36.6K
WINA icon
2849
Winmark
WINA
$1.2B
$4.78M ﹤0.01%
63,207
+1,926
+3% +$157K
FFKT
2850
DELISTED
Farmers Capital Bank Corp
FFKT
$4.78M ﹤0.01%
212,642
+2,725
+1% +$56.4K

Similar funds

BlackRock Fund Advisors's Q1 2014 Portfolio in Review

As of Q1 2014, BlackRock Fund Advisors held 3,915 positions worth $337B, up 2.6% from $329B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.

Trading was light in Q1 2014: portfolio turnover was 3%. BlackRock Fund Advisors opened 60 new positions and exited 56, leaving the 3,915-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Technology.

  • BlackRock Fund Advisors's largest Q1 2014 buy was Perrigo: 1,983,330 shares worth $307M.
  • BlackRock Fund Advisors added most to Verizon in Q1 2014, an estimated $563M increase.
  • BlackRock Fund Advisors's biggest Q1 2014 reduction was iShares MSCI EAFE ETF, cutting an estimated $376M.
  • BlackRock Fund Advisors fully exited Endo International plc in Q1 2014, selling an estimated $320M.
  • BlackRock Fund Advisors's ten largest holdings make up 9.7% of its $337B portfolio in Q1 2014.
  • BlackRock Fund Advisors opened 60 new positions and closed 56 in Q1 2014.
  • BlackRock Fund Advisors's portfolio value rose 2.6% quarter-over-quarter to $337B.

Based on BlackRock Fund Advisors's 13F filing for Q1 2014, filed 2 May 2014.